ESBATech, a Novartis company Revenue

Biotechnology Research • Schlieren, Zurich, Switzerland • 11-20 Employees

ESBATech, a Novartis company revenue & valuation

Annual revenue	$1,112,215
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,600,000
Total funding	$22,000,000

Key Contacts at ESBATech, a Novartis company

Georges Weissgerber

Medical Director And Head Cr&D

Peter Lichtlen

Medical Director

Company overview

Headquarters	Wagistrasse 12, Schlieren-Zurich, 8952, CH
Phone number	+414447388080
Website	esbatech.com
NAICS	541714
Founded	1998
Employees	11-20
Socials

ESBATech, a Novartis company Email Formats

ESBATech, a Novartis company uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.

Format	Example	Percentage
{first name}.{last name}@company.com	john.doe@company.com	42.1%
{first name}@company.com	john@company.com	25.3%
{first name initial}{last name}@company.com	{first name initial}doe@company.com	14.8%
{first name}{last name}@company.com	johndoe@company.com	10.2%
{last name}@company.com	doe@company.com	7.6%

About ESBATech, a Novartis company

ESBATech is a Zurich, Switzerland based company of Novartis and part of the Ophthalmology Disease Area research team of the Novartis Institutes for BioMedical Research (NIBR). ESBATech has proprietary antibody fragment technology and strong expertise in biologics research and development up to clinical Proof-of-Concept. It couples its capabilities with pathways research, biologics technologies, and other platforms in NIBR and Alcon to develop new and effective treatments for a wide range of sight-threatening eye diseases with high unmet need, including age-related macular degeneration, diabetic retinopathy, uveitis, glaucoma and dry eye.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Head

Director

Employees by Department

ESBATech, a Novartis company has 7 employees across 3 departments.

Departments

Number of employees

Funding Data

Explore ESBATech, a Novartis company's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2008-09-07	5	$22,000,000

Funding Insights

$22,000,000

Total funding amount

$22,000,000

Most recent funding amount

Number of funding rounds

Frequently asked questions

ESBATech, a Novartis company is located in Schlieren, Zurich, CH.

You can reach ESBATech, a Novartis company at +414447388080.

ESBATech, a Novartis company generates an estimated annual revenue of $1,112,215. This revenue figure reflects the company's market position and business performance in its industry.

ESBATech, a Novartis company has an estimated valuation of $3,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ESBATech, a Novartis company was founded in 1998, making it 28 years old. The company has established itself as a significant player in its industry over this time.

ESBATech, a Novartis company has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

ESBATech, a Novartis company has raised a total of $22,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at ESBATech, a Novartis company

Georges Weissgerber

Medical Director And Head Cr&D

Peter Lichtlen

Medical Director

4.8

40,000 users